Search results
Results from the WOW.Com Content Network
A remission may be considered a partial remission or a complete remission. Each disease, type of disorder , or clinical trial can have its own definition of a partial remission. For example, a partial remission for cancer may be defined as a 50% or greater reduction in the measurable parameters of tumor growth as may be found on physical ...
The major efficacy outcome measures were rate and duration of complete remission achieved within three months after infusion. [2] Additional outcome measures were rate and duration of overall complete remission which includes complete remission and complete remission with incomplete hematologic recovery, at any time. [ 2 ]
Efficacy was established based on the rate of complete remission (CR) and CR duration. [18] Study M14-358 (NCT02203773) was a non-randomized, open-label clinical trial of venetoclax in combination with azacitidine (n=67) or decitabine (n=13) in newly diagnosed participants with AML. [18]
Studies on small numbers of individuals with the disease have found that the standard chemotherapy regimens used for the initial induction treatments of AML, acute lymphoblastic leukemia, and high-grade lymphoma give complete remission rates of 77%, 93%, and 80%, respectively, in childhood PBDN and 47%, 77%, and 53%, respectively, in adult PBDN.
People in pediatric care with ALL in developed countries have a greater than 80% five-year survival rate. It is estimated that 60–80% of adults undergoing induction chemotherapy achieve complete remission after 4 weeks, and those over the age of 70 have a cure rate of 5%. [48] [75]
Firstly, the complete remission rates were not high in any group. The study did not confirm Dr Holt’s previous reports of a 100% response rate for bladder tumours (Holt, 1988). The initial response rate (complete response and partial response) was 50% for RT alone, 34% for RT + UHF and 17% for UHF + GBA.
The simplest cure rate model was published by Joseph Berkson and Robert P. Gage in 1952. [7] In this model, the survival at any given time is equal to those that are cured plus those that are not cured, but who have not yet died or, in the case of diseases that feature asymptomatic remissions, have not yet re-developed signs and symptoms of the ...
However, such techniques can be useful in confirming complete pathological response when biopsies are obtained. Tumor markers alone cannot be used to assess response. If markers are initially above the upper normal limit, they must normalize for a patient to be considered in complete clinical response when all lesions have disappeared.